299 related articles for article (PubMed ID: 27587228)
21. Parotid perfusion in nasopharyngeal carcinoma patients in early-to-intermediate stage after low-dose intensity-modulated radiotherapy: evaluated by fat-saturated dynamic contrast-enhanced magnetic resonance imaging.
Cheng CC; Chiu SC; Jen YM; Chang HC; Chung HW; Liu YJ; Chiu HC; Chen CY; Huang GS; Juan CJ
Magn Reson Imaging; 2013 Oct; 31(8):1278-84. PubMed ID: 23664679
[TBL] [Abstract][Full Text] [Related]
22. DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients.
Huang W; Zhang Q; Wu G; Chen PP; Li J; McCabe Gillen K; Spincemaille P; Chiang GC; Gupta A; Wang Y; Chen F
Radiother Oncol; 2021 Nov; 164():146-154. PubMed ID: 34592360
[TBL] [Abstract][Full Text] [Related]
23. Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.
Yu XP; Hou J; Li FP; Xiang W; Lu Q; Hu Y; Wang H
Dentomaxillofac Radiol; 2016; 45(3):20150317. PubMed ID: 26846711
[TBL] [Abstract][Full Text] [Related]
24. Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage.
Huang B; Wong CS; Whitcher B; Kwong DL; Lai V; Chan Q; Khong PL
Eur Radiol; 2013 Jun; 23(6):1495-502. PubMed ID: 23377545
[TBL] [Abstract][Full Text] [Related]
25. Nasopharyngeal carcinoma perfusion MRI: Comparison of arterial spin labeling and dynamic contrast-enhanced MRI.
Xiao B; Wang P; Zhao Y; Liu Y; Ye Z
Medicine (Baltimore); 2020 May; 99(22):e20503. PubMed ID: 32481470
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
27. Value of dynamic contrast-enhanced magnetic resonance imaging for determining the plasma Epstein-Barr virus status and staging of nasopharyngeal carcinoma.
Sriyook A; Lertbutsayanukul C; Jittapiromsak N
Clin Imaging; 2021 Apr; 72():1-7. PubMed ID: 33190027
[TBL] [Abstract][Full Text] [Related]
28. Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients.
Jensen LR; Garzon B; Heldahl MG; Bathen TF; Lundgren S; Gribbestad IS
J Magn Reson Imaging; 2011 Nov; 34(5):1099-109. PubMed ID: 22002757
[TBL] [Abstract][Full Text] [Related]
29. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
[TBL] [Abstract][Full Text] [Related]
30. Monitoring neoadjuvant chemotherapy in breast cancer patients: improved MR assessment at 3 T?
Heldahl MG; Lundgren S; Jensen LR; Gribbestad IS; Bathen TF
J Magn Reson Imaging; 2011 Sep; 34(3):547-56. PubMed ID: 21761463
[TBL] [Abstract][Full Text] [Related]
31. DCE-MRI time-intensity curve visual inspection to assess pathological response after neoadjuvant therapy in locally advanced rectal cancer.
Petrillo A; Fusco R; Petrillo M; Granata V; Bianco F; Di Marzo M; Delrio P; Tatangelo F; Botti G; Pecori B; Avallone A
Jpn J Radiol; 2018 Oct; 36(10):611-621. PubMed ID: 30039258
[TBL] [Abstract][Full Text] [Related]
32. Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer.
Schaafsma BE; van de Giessen M; Charehbili A; Smit VT; Kroep JR; Lelieveldt BP; Liefers GJ; Chan A; Löwik CW; Dijkstra J; van de Velde CJ; Wasser MN; Vahrmeijer AL
Clin Cancer Res; 2015 Feb; 21(3):577-84. PubMed ID: 25473002
[TBL] [Abstract][Full Text] [Related]
33. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
[TBL] [Abstract][Full Text] [Related]
34. Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Regional Nodal Metastasis in Nasopharyngeal Carcinoma: Correlation with Nodal Staging.
Huang B; Kwong DL; Lai V; Chan Q; Whitcher B; Khong PL
Contrast Media Mol Imaging; 2017; 2017():4519653. PubMed ID: 29097922
[TBL] [Abstract][Full Text] [Related]
35. [Quantitative assessment of vasculature with DCE-MRI in nasopharyngeal carcinomas following radiotherapy and its value for efficacy evaluation].
Liao W; Yang L; Jiang W; Sun L; Cao Y; Wang X
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jul; 35(7):954-9. PubMed ID: 26198942
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of olfactory neuroblastomas from nasal squamous cell carcinomas using MR diffusion kurtosis imaging and dynamic contrast-enhanced MRI.
Xiao Z; Tang Z; Qiang J; Qian W; Zhong Y; Wang R; Wang J; Wu L; Tang W
J Magn Reson Imaging; 2018 Feb; 47(2):354-361. PubMed ID: 28661554
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
Kang SR; Kim HW; Kim HS
J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
[TBL] [Abstract][Full Text] [Related]
38. Investigating the correlation of arterial spin labeling and dynamic contrast enhanced perfusion in primary tumor of nasopharyngeal carcinoma.
Lin M; Yu X; Luo D; Ouyang H; Xie L; Wu B; Zhou C
Eur J Radiol; 2018 Nov; 108():222-229. PubMed ID: 30396660
[TBL] [Abstract][Full Text] [Related]
39. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy.
Pickles MD; Lowry M; Manton DJ; Gibbs P; Turnbull LW
Breast Cancer Res Treat; 2005 May; 91(1):1-10. PubMed ID: 15868426
[TBL] [Abstract][Full Text] [Related]
40. Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Tong T; Sun Y; Gollub MJ; Peng W; Cai S; Zhang Z; Gu Y
J Magn Reson Imaging; 2015 Sep; 42(3):673-80. PubMed ID: 25652254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
